Anixa Biosciences, Inc. (ANIX) delivered a return of -19.10% over the past year. Since ANIX does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in Anixa Biosciences, Inc. one year ago would be worth $8,090 today, representing a loss of $1,910.

Anixa Biosciences, Inc. (ANIX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For ANIX, the total return equals the price-only return.

No, Anixa Biosciences, Inc. (ANIX) underperformed the S&P 500 by 39.94 percentage points over the past year. ANIX delivered a total return of -19.10%, compared to the S&P 500's 20.84%. This means a passive S&P 500 index fund outperformed ANIX by 39.94pp during this period.

Anixa Biosciences, Inc. (ANIX) experienced a maximum drawdown of -54.98% over the past year, declining from its peak on 2025-12-08 to its trough on 2026-06-10. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Here are Anixa Biosciences, Inc. (ANIX)'s long-term returns with dividends reinvested. Over 10 years, the total return is -14.7% (-1.6% CAGR) — $10,000 would have grown to $8,525. Over 20 years: -85.8% total return (-9.3% CAGR) — $10,000 → $1,418. Over 30 years: -98.6% total return (-13.2% CAGR) — $10,000 → $144. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Anixa Biosciences, Inc.'s best calendar year was 2003 with a total return of 170.6%. Its worst year was 2008 with a total return of -71.1%. This range shows the volatility investors should expect — the difference between the best and worst year is 241.7 percentage points.